(Q36410337)

English

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

adaptive radiation therapy

0 references

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

15

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Dirk De Ruysscher

20

object named as

Dirk De Ruysscher

1 reference

Europe PubMed Central

14 August 2017

PMC publication ID

1

object named as

Hugo J W L Aerts

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Angela A W van Baardwijk

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Steven F Petit

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Claudia Offermann

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Judith van Loon

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Ruud Houben

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Anne-Marie C Dingemans

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Rinus Wanders

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Liesbeth Boersma

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Jacques Borger

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Gerben Bootsma

11

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Wiel Geraedts

12

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Cordula Pitz

13

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Jean Simons

14

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Michel Oellers

16

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Philippe Lambin

17

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Geert Bosmans

18

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Andre L A J Dekker

19

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

28 March 2009

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Radiotherapy and Oncology

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

91

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

386-392

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Hypoxia dose painting by numbers: a planning study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Theragnostic imaging for radiation oncology: dose-painting by numbers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Functional imaging of intratumoral hypoxia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Positron emission tomography provides molecular imaging of biological processes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

30 September 2017

Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Routine individualised patient dosimetry using electronic portal imaging devices.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

A challenge to traditional radiation oncology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Sample size tables for exact single-stage phase II designs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 September 2018

Dose painting: art or science?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

21 October 2018

Individualized Radical Radiotherapy of Non–Small-Cell Lung Cancer Based on Normal Tissue Dose Constraints: A Feasibility Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

5 December 2018

Radiotherapy Adapted to Spatial and Temporal Variability in Tumor Hypoxia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693609

5 December 2018

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19329207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19329207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix

1 reference

https://pubmed.ncbi.nlm.nih.gov/19329207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19329207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19329207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.RADONC.2009.03.006

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36410337&oldid=2137664928"